Aspects of human cytomegalovirus latency and reactivation

Current Topics in Microbiology and Immunology

Volumn 325, Issue , 2008, Pages 297-313

  Reeves, M ^a   Sinclair, J ^b  

^a NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD DONOR; BONE MARROW CELL; CD34 SELECTION; CELL LINEAGE; CELL SUBPOPULATION; CHROMATIN STRUCTURE; CYTOTOXIC T LYMPHOCYTE; DISEASE ASSOCIATION; EXPERIMENTAL INFECTION; GENE EXPRESSION; GRAFT INFECTION; GRAFT RECIPIENT; HUMAN; HUMAN CYTOMEGALOVIRUS; IMMUNOCOMPROMISED PATIENT; LATENT PERIOD; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; REVIEW; VIRUS CARRIER; VIRUS ETIOLOGY; VIRUS GENE; VIRUS GENOME; VIRUS LATENCY; VIRUS MORPHOGENESIS; VIRUS PATHOGENESIS; VIRUS REACTIVATION; VIRUS SURVIVAL; CYTOMEGALOVIRUS; PHYSIOLOGY; VIROLOGY; VIRUS ACTIVATION;

HUMAN HERPESVIRUS 5;

VIRUS PROTEIN;

CYTOMEGALOVIRUS; HUMANS; MYELOID CELLS; VIRAL PROTEINS; VIRUS ACTIVATION; VIRUS LATENCY;

EID: 42249103647     PISSN: 0070217X     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-540-77349-8_17     Document Type: Review

References (92)

1. Adams A (1987) Replication of latent Epstein-Barr virus genomes in Raji cells. J Virol 61:1743-1746
2. Adler SP (1983) Transfusion-associated cytomegalovirus infections. Rev Infect Dis 5:977-993
3. Bain M, Mendelson M, Sinclair J (2003) Ets-2 repressor factor (ERF) mediates repression of the human cytomegalovirus major immediate-early promoter in undifferentiated non-permissive cells. J Gen Virol 84:41-49
4. Bego MG, St Jeor S (2006) Human cytomegalovirus infection of cells of hematopoietic origin: HCMV-induced immunosuppression, immune evasion, and latency. Exp Hematol 34:555-570
5. Bego M, Maciejewski J, Khaiboullina S, Pari G, St Jeor S (2005) Characterization of an antisense transcript spanning the UL81-82 locus of human cytomegalovirus. J Virol 79:11022-11034
6. Beisser PS, Laurent L, Virelizier JL, Michelson S (2001) Human cytomegalovirus chemokine receptor gene US28 is transcribed in latently infected THP-1 monocytes. J Virol 75:5949-5957
7. Bevan IS, Daw RA, Day PJ, Ala FA, Walker MR (1991) Polymerase chain reaction for detection of human cytomegalovirus infection in a blood donor population. Br J Haematol 78:94-99
8. Bolovan-Fritts CA, Mocarski ES, Wiedeman JA (1999) Peripheral blood CD14(+) cells from healthy subjects carry a circular conformation of latent cytomegalovirus genome. Blood 93:394-398
9. Bresnahan WA, Shenk TE (2000) UL82 virion protein activates expression of immediate early viral genes in human cytomegalovirus-infected cells. Proc Natl Acad Sci USA 97:14506-14511
10. Cheung AK, Abendroth A, Cunningham AL, Slobedman B (2006) Viral gene expression during the establishment of human cytomegalovirus latent infection in myeloid progenitor cells. Blood 108:3691-3699
11. Cotter MA 2nd, Robertson ES (1999) The latency-associated nuclear antigen tethers the Kaposi's sarcoma-associated herpesvirus genome to host chromosomes in body cavity-based lymphoma cells. Virology 264:254-264
12. Danesh J, Collins R, Peto R (1997) Chronic infections and coronary heart disease: is there a link? Lancet 350:430-436
13. Epstein SE, Speir E, Zhou YF, Guetta E, Leon M, Finkel T (1996) The role of infection in restenosis and atherosclerosis: focus on cytomegalovirus. Lancet 348 [Suppl 1]:s13-s17
14. Everett RD (2006) Interactions between DNA viruses, ND10 and the DNA damage response. Cell Microbiol 8:365-374
15. Fish KN, Stenglein SG, Ibanez C, Nelson JA (1995) Cytomegalovirus persistence in macrophages and endothelial cells. Scand J Infect Dis Suppl 99:34-40
16. Fish KN, Soderberg-Naucler C, Mills LK, Stenglein S, Nelson JA (1998) Human cytomegalovirus persistently infects aortic endothelial cells. J Virol 72:5661-5668
17. Fortunato EA, McElroy AK, Sanchez I, Spector DH (2000) Exploitation of cellular signaling and regulatory pathways by human cytomegalovirus. Trends Microbiol 8:111-119
18. Gilbert GL, Hayes K, Hudson IL, James J (1989) Prevention of transfusion-acquired cytomegalovirus infection in infants by blood filtration to remove leucocytes. Neonatal Cytomegalovirus Infection Study Group. Lancet 1:1228-1231
19. Goodrum FD, Jordan CT, High K, Shenk T (2002) Human cytomegalovirus gene expression during infection of primary hematopoietic progenitor cells: a model for latency. Proc Natl Acad Sci USA 99:16255-16260
20. Goodrum F, Jordan CT, Terhune SS, High K, Shenk T (2004) Differential outcomes of human cytomegalovirus infection in primitive hematopoietic cell subpopulations. Blood 104:687-695
21. Goodrum F, Reeves M, Sinclair J, High K, Shenk T (2007) Human cytomegalovirus sequences expressed in latently infected individuals promote a latent infection in vitro. Blood 110:937-945
22. Griffiths PD, Walter S (2005) Cytomegalovirus. Curr Opin Infect Dis 18:241-245
23. Hahn G, Jores R, Mocarski ES (1998) Cytomegalovirus remains latent in a common precursor of dendritic and myeloid cells. Proc Natl Acad Sci USA 95:3937-3942
24. Ho M (1990) Epidemiology of cytomegalovirus infections. Rev Infect Dis 12 [Suppl 7]:S701-S710
25. Ioudinkova E, Arcangeletti MC, Rynditch A, De Conto F, Motta F, Covan S, Pinardi F, Razin SV, Chezzi C (2006) Control of human cytomegalovirus gene expression by differential histone modifications during lytic and latent infection of a monocytic cell line. Gene 384:120-128
26. Jarvis MA, Nelson JA (2007) Human cytomegalovirus tropism for endothelial cells: not all endothelial cells are created equal. J Virol 81:2095-2101
27. Jenkins C, Abendroth A, Slobedman B (2004) A novel viral transcript with homology to human interleukin-10 is expressed during latent human cytomegalovirus infection. J Virol 78:1440-1447
28. Johnson DC, Hegde NR (2002) Inhibition of the MHC class II antigen presentation pathway by human cytomegalovirus. Curr Top Microbiol Immunol 269:101-115
29. Kahl M, Siegel-Axel D, Stenglein S, Jahn G, Sinzger C (2000) Efficient lytic infection of human arterial endothelial cells by human cytomegalovirus strains. J Virol 74:7628-7635
30. Kondo K, Mocarski ES (1995) Cytomegalovirus latency and latency-specific transcription in hematopoietic progenitors. Scand J Infect Dis Suppl 99:63-67
31. Kondo K, Kaneshima H, Mocarski ES (1994) Human cytomegalovirus latent infection of granulocyte-macrophage progenitors. Proc Natl Acad Sci USA 91:11879-11883
32. Kondo K, Xu J, Mocarski ES (1996) Human cytomegalovirus latent gene expression in granulocyte-macrophage progenitors in culture and in seropositive individuals. Proc Natl Acad Sci USA 93:11137-11142
33. Kotenko SV, Saccani S, Izotova LS, Mirochnitchenko OV, Pestka S (2000) Human cytomegalovirus harbors its own unique IL-10 homolog (cmvIL-10). Proc Natl Acad Sci USA 97:1695-1700
34. Landini MP, Lazzarotto T, Xu J, Geballe AP, Mocarski ES (2000) Humoral immune response to proteins of human cytomegalovirus latency-associated transcripts. Biol Blood Marrow Transplant 6:100-108
35. Leight ER, Sugden B (2000) EBNA-1: a protein pivotal to latent infection by Epstein-Barr virus. Rev Med Virol 10:83-100
36. Liu B, Stinski MF (1992) Human cytomegalovirus contains a tegument protein that enhances transcription from promoters with upstream ATF and AP-1 cis-acting elements. J Virol 66:4434-4444
37. Liu R, Baillie J, Sissons JG, Sinclair JH (1994) The transcription factor YY1 binds to negative regulatory elements in the human cytomegalovirus major immediate early enhancer/promoter and mediates repression in non-permissive cells. Nucleic Acids Res 22:2453-2459
38. Lunetta JM, Wiedeman JA (2000) Latency-associated sense transcripts are expressed during in vitro human cytomegalovirus productive infection. Virology 278:467-476
39. Maciejewski JP, St Jeor SC (1999) Human cytomegalovirus infection of human hematopoietic progenitor cells. Leuk Lymphoma 33:1-13
40. Maussang D, Verzijl D, van Walsum M, Leurs R, Holl J, Pleskoff O, Michel D, van Dongen GA, Smit MJ (2006) Human cytomegalovirus-encoded chemokine receptor US28 promotes tumorigenesis. Proc Natl Acad Sci USA 103:13068-13073
41. McLaughlin-Taylor E, Pande H, Forman SJ, Tanamachi B, Li CR, Zaia JA, Greenberg PD, Riddell SR (1994) Identification of the major late human cytomegalovirus matrix protein pp65 as a target antigen for CD8+ virus-specific cytotoxic T lymphocytes. J Med Virol 43:103-110
42. Meier JL (2001) Reactivation of the human cytomegalovirus major immediate-early regulatory region and viral replication in embryonal NTera2 cells: role of trichostatin A, retinoic acid, and deletion of the 21-base-pair repeats and modulator. J Virol 75:1581-1593
43. Meier JL, Stinski MF (1996) Regulation of human cytomegalovirus immediate-early gene expression. Intervirology 39:331-342
44. Mendelson M, Monard S, Sissons P, Sinclair J (1996) Detection of endogenous human cytomegalovirus in CD34+ bone marrow progenitors. J Gen Virol 77:3099-3102
45. Metcalf D (1989) The molecular control of cell division, differentiation commitment and maturation in haemopoietic cells. Nature 339:27-30
46. Minton EJ, Tysoe C, Sinclair JH, Sissons JG (1994) Human cytomegalovirus infection of the monocyte/macrophage lineage in bone marrow. J Virol 68:4017-4021
47. Mocarski ES, Hahn G, White KL, Xu J, Slobedman B, Hertel L, Aguirre SA, Noda S (2006) Myeloid cell recruitment and function in pathogenesis and latency. In: Reddehase MJ (ed) Cytomegaloviruses: molecular biology and immunology. Caister, Wymondon, UK, pp 465-481
48. Monji T, Petersons J, Saund NK, Vuckovic S, Hart DN, Auditore-Hargreaves K, Risdon G (2002) Competent dendritic cells derived from CD34+ progenitors express CMRF-44 antigen early in the differentiation pathway. Immunol Cell Biol 80:216-225
49. Murphy JC, Fischle W, Verdin E, Sinclair JH (2002) Control of cytomegalovirus lytic gene expression by histone acetylation. EMBO J 21:1112-1120
50. Nevels M, Paulus C, Shenk T (2004) Human cytomegalovirus immediate-early 1 protein facilitates viral replication by antagonizing histone deacetylation. Proc Natl Acad Sci USA 101:17234-17239
51. O'Garra A, Trinchieri G (2004) Are dendritic cells afraid of commitment? Nat Immunol 5:1206-1208
52. Olweus J, BitMansour A, Warnke R, Thompson PA, Carballido J, Picker LJ, Lund-Johansen F (1997) Dendritic cell ontogeny: a human dendritic cell lineage of myeloid origin. Proc Natl Acad Sci USA 94:12551-12556
53. Peggs KS, Mackinnon S (2004) Cytomegalovirus: the role of CMV post-haematopoietic stem cell transplantation. Int J Biochem Cell Biol 36:695-701
54. Plachter B, Sinzger C, Jahn G (1996) Cell types involved in replication and distribution of human cytomegalovirus. Adv Virus Res 46:195-261
55. Quirici N, Soligo D, Caneva L, Servida F, Bossolasco P, Deliliers GL (2001) Differentiation and expansion of endothelial cells from human bone marrow CD133(+) cells. Br J Haematol 115:186-194
56. Reeves MB, Coleman H, Chadderton J, Goddard M, Sissons JG, Sinclair JH (2004) Vascular endothelial and smooth muscle cells are unlikely to be major sites of latency of human cytomegalovirus in vivo. J Gen Virol 85:3337-3341
57. Reeves MB, Lehner PJ, Sissons JG, Sinclair JH (2005a) An in vitro model for the regulation of human cytomegalovirus latency and reactivation in dendritic cells by chromatin remodelling. J Gen Virol 86:2949-2954
58. Reeves MB, MacAry PA, Lehner PJ, Sissons JG, Sinclair JH (2005b) Latency, chromatin remodeling, and reactivation of human cytomegalovirus in the dendritic cells of healthy carriers. Proc Natl Acad Sci USA 102:4140-4145
59. Reeves M, Murphy J, Greaves R, Fairley J, Brehm A, Sinclair J (2006) Autorepression of the human cytomegalovirus major immediate-early promoter/enhancer at late times of infection is mediated by the recruitment of chromatin remodeling enzymes by IE86. J Virol 80:9998-10009
60. Reinhardt B, Winkler M, Schaarschmidt P, Pretsch R, Zhou S, Vaida B, Schmid-Kotsas A, Michel D, Walther P, Bachem M, Mertens T (2006) Human cytomegalovirus-induced reduction of extracellular matrix proteins in vascular smooth muscle cell cultures: a pathomechanism in vasculopathies? J Gen Virol 87:2849-2858
61. Riddell SR, Rabin M, Geballe AP, Britt WJ, Greenberg PD (1991) Class I MHC-restricted cytotoxic T lymphocyte recognition of cells infected with human cytomegalovirus does not require endogenous viral gene expression. J Immunol 146:2795-2804
62. Rubin RH (1990) Impact of cytomegalovirus infection on organ transplant recipients. Rev Infect Dis 12 [Suppl 7]:S754-S766
63. Schierling K, Stamminger T, Mertens T, Winkler M (2004) Human cytomegalovirus tegument proteins ppUL82 (pp71) and ppUL35 interact and cooperatively activate the major immediate-early enhancer. J Virol 78:9512-9523
64. Simmen KA, Singh J, Luukkonen BG, Lopper M, Bittner A, Miller NE, Jackson MR, Compton T, Fruh K (2001) Global modulation of cellular transcription by human cytomegalovirus is initiated by viral glycoprotein B. Proc Natl Acad Sci USA 98:7140-7145
65. Sinclair J, Sissons P (1996) Latent and persistent infections of monocytes and macrophages. Intervirology 39:293-301
66. Sinclair J, Sissons P (2006) Latency and reactivation of human cytomegalovirus. J Gen Virol 87:1763-1779
67. Sindre H, Tjoonnfjord GE, Rollag H, Ranneberg-Nilsen T, Veiby OP, Beck S, Degre M, Hestdal K (1996) Human cytomegalovirus suppression of and latency in early hematopoietic progenitor cells. Blood 88:4526-4533
68. Sinzger C, Grefte A, Plachter B, Gouw AS, The TH, Jahn G (1995) Fibroblasts, epithelial cells, endothelial cells and smooth muscle cells are major targets of human cytomegalovirus infection in lung and gastrointestinal tissues. J Gen Virol 76:741-750
69. Sissons JG, Carmichael AJ (2002) Clinical aspects and management of cytomegalovirus infection. J Infect 44:78-83
70. Sissons JG, Bain M, Wills MR (2002) Latency and reactivation of human cytomegalovirus. J Infect 44:73-77
71. Slobedman B, Mocarski ES (1999) Quantitative analysis of latent human cytomegalovirus. J Virol 73:4806-4812
72. Slobedman B, Mocarski ES, Arvin AM, Mellins ED, Abendroth A (2002) Latent cytomegalovirus down-regulates major histocompatibility complex class II expression on myeloid progenitors. Blood 100:2867-2873
73. Slobedman B, Stern JL, Cunningham AL, Abendroth A, Abate DA, Mocarski ES (2004) Impact of human cytomegalovirus latent infection on myeloid progenitor cell gene expression. J Virol 78:4054-4062
74. Soderberg-Naucler C, Fish KN, Nelson JA (1997) Reactivation of latent human cytomegalovirus by allogeneic stimulation of blood cells from healthy donors. Cell 91:119-126
75. Soderberg-Naucler C, Streblow DN, Fish KN, Allan-Yorke J, Smith PP, Nelson JA (2001) Reactivation of latent human cytomegalovirus in CD14(+) monocytes is differentiation dependent. J Virol 75:7543-7554
76. Spencer JV, Lockridge KM, Barry PA, Lin G, Tsang M, Penfold ME, Schall TJ (2002) Potent immunosuppressive activities of cytomegalovirus-encoded interleukin-10. J Virol 76:1285-1292
77. Stanier P, Kitchen AD, Taylor DL, Tyms AS (1992) Detection of human cytomegalovirus in peripheral mononuclear cells and urine samples using PCR. Mol Cell Probes 6:51-58
78. Streblow DN, Nelson JA (2003) Models of HCMV latency and reactivation. Trends Microbiol 11:293-295
79. Sylwester AW, Mitchell BL, Edgar JB, Taormina C, Pelte C, Ruchti F, Sleath PR, Grabstein KH, Hosken NA, Kern F, Nelson JA, Picker LJ (2005) Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects. J Exp Med 202:673-685
80. Taylor-Wiedeman J, Sissons JG, Borysiewicz LK, Sinclair JH (1991) Monocytes are a major site of persistence of human cytomegalovirus in peripheral blood mononuclear cells. J Gen Virol 72:2059-2064
81. Taylor-Wiedeman J, Hayhurst GP, Sissons JG, Sinclair JH (1993) Polymorphonuclear cells are not sites of persistence of human cytomegalovirus in healthy individuals. J Gen Virol 74:265-268
82. Taylor-Wiedeman J, Sissons P, Sinclair J (1994) Induction of endogenous human cytomegalovirus gene expression after differentiation of monocytes from healthy carriers. J Virol 68:1597-1604
83. Thomas MJ, Seto E (1999) Unlocking the mechanisms of transcription factor YY1: are chromatin modifying enzymes the key? Gene 236:197-208
84. Tolpin MD, Stewart JA, Warren D, Mojica BA, Collins MA, Doveikis SA, Cabradilla C Jr, Schauf V, Raju TN, Nelson K (1985) Transfusion transmission of cytomegalovirus confirmed by restriction endonuclease analysis. J Pediatr 107:953-956
85. White KL, Slobedman B, Mocarski ES (2000) Human cytomegalovirus latency-associated protein pORF94 is dispensable for productive and latent infection. J Virol 74:9333-9337
86. Wills MR, Carmichael AJ, Mynard K, Jin X, Weekes MP, Plachter B, Sissons JG (1996) The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: frequency, specificity, and T-cell receptor usage of pp65-specific CTL. J Virol 70:7569-7579
87. Wright E, Bain M, Teague L, Murphy J, Sinclair J (2005) Ets-2 repressor factor recruits histone deacetylase to silence human cytomegalovirus immediate-early gene expression in non-permissive cells. J Gen Virol 86:535-544
88. Yates J, Warren N, Reisman D, Sugden B (1984) A cis-acting element from the Epstein-Barr viral genome that permits stable replication of recombinant plasmids in latently infected cells. Proc Natl Acad Sci USA 81:3806-3810
89. Yeager AS, Grumet FC, Hafleigh EB, Arvin AM, Bradley JS, Prober CG (1981) Prevention of transfusion-acquired cytomegalovirus infections in newborn infants. J Pediatr 98:281-287
90. Young LS, Dawson CW, Eliopoulos AG (2000) The expression and function of Epstein-Barr virus encoded latent genes. Mol Pathol 53:238-247
91. Zaia JA (1990) Epidemiology and pathogenesis of cytomegalovirus disease. Semin Hematol 27:5-10; discussion 28-19
92. Zweidler-Mckay PA, Grimes HL, Flubacher MM, Tsichlis PN (1996) Gfi-1 encodes a nuclear zinc finger protein that binds DNA and functions as a transcriptional repressor. Mol Cell Biol 16:4024-4034